tirzepatide and blood clots Can Mounjaro Injection Cause Clots? UK Guide Deep Vein Thrombosis - Vein

Description About the Product: Semaglutide (GLP-1) is a glucagon-like peptide-1 receptor agonist studied for its role in regulating appetite, improving blood sugar control, and supporting weight management

For weight management , certain GLP-1 formulations (liraglutide 3.0mg [Saxenda] and semaglutide 2.4mg [Wegovy]) are licensed for chronic weight management in adults with: BMI 30 kg/m , or BMI 27 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, or dyslipidaemia) However, NHS access to these medications for weight management is typically restricted to specialist tier 3 or tier 4 weight management services, with specific eligibility criteria defined by NICE technology appraisals (TA494 for liraglutide, TA664 for semaglutide) and local commissioning arrangements

GLP-1, or glucagon-like peptide-1, is a hormone your body naturally produces to signal that you are full

Goal: Metabolic health improvement (A1C, lipids, insulin sensitivity) Choice: Tirzepatide